A recent study by Triton Market Research titled ‘Global Surgical Sutures Market,’ covers the Global Analysis and Forecasts by Type (Monofilament, Multifilament), by Product Type (Sutures [Absorbable Sutures {Synthetic Sutures (Monocryl Sutures, Vicryl Sutures, Polyglycolic Sutures, Polydioxanone Sutures, Other Synthetic Sutures), Natural Sutures}, Non-absorbable Sutures {Nylon Sutures, Stainless Steel Sutures, Prolene Sutures, Other Non-absorbable Sutures}], Automated Suturing Device), by Application (General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Gynecology Surgery, Ophthalmic Surgery, Other Applications), and by Regional Outlook (North America; Europe; Asia-Pacific; Latin America; the Middle East and Africa), and Regional Outlook (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa).
Request Free Sample of the Global Surgical Sutures Market Report @
https://www.tritonmarketresearch.com/reports/surgical-sutures-market#request-free-sample
A report by Triton Market Research predicts the global surgical sutures market to grow with a CAGR of 5.74% in the forecast years 2022-2028. This market is likely to accumulate revenue worth $5131.56 million by 2028.
Minimally invasive surgeries are becoming increasingly popular. These procedures are milder and less stressful on the body than conventional procedures. The many benefits of minimally invasive surgery provide compared to traditional open surgery include less pain, smaller & fewer scars, lower costs, shorter hospital stays & recovery times, and overall better outcomes. These factors have raised their demand in recent years. The rise in minimally invasive surgeries is expected to contribute to the growth of the surgical sutures market.
However, today, a number of alternative wound care treatments are available, which assist in speeding up the healing process and reducing scarring. This factor is likely to affect the adoption rate of surgical sutures, consequently hampering the market’s growth.
The market for surgical sutures is segmented into type, product type, and application. Based on type, it is divided into monofilament and multifilament. Based on product type, it is bifurcated broadly into sutures and automated suturing device. The sutures sub-segment is further divided into absorbable sutures and non-absorbable sutures. Absorbable sutures consist of synthetic sutures and natural sutures.
Synthetic sutures comprise monocryl sutures, vicryl sutures, polyglycolic sutures, polydioxanone sutures, and other synthetic sutures. On the other hand, non-absorbable sutures consist of nylon sutures, stainless steel sutures, prolene sutures, and other non-absorbable sutures. Lastly, according to application, the market is classified into general surgery, cardiovascular surgery, orthopedic surgery, gynecology surgery, ophthalmic surgery, and other applications.
The market in North America is presently the largest globally, and is expected to continue its lead until the end of the forecast period. According to data from the Canadian Medical Protective Association (CMPA), over 1 million surgical procedures are performed in Canada every year.
In addition, hip & knee replacement procedures and cosmetic surgeries are on the rise in North America. Besides, the number of ambulatory surgery centers (ASCs) in the region is also growing. These developments necessitate the demand for surgical sutures. The rise in demand is expected to propel the market in North America forward in the projected period.
Stryker Corporation, Teleflex Incorporated, Ethicon Inc (Johnson & Johnson), Boston Scientific Corporation, Smith & Nephew Plc, Advanced Medical Solutions Group Plc (AMS Group), Medtronic Plc, Demetech Corporation, Lotus Surgicals, Zimmer Biomet Holdings Inc, Conmed Corporation, Unisur Lifecare Pvt Ltd, Internacional Farmaceutica SA De CV, Corza Medical, and B Braun Melsungen AG are the well-known players in the surgical sutures market.
Purchase this Report @ https://www.tritonmarketresearch.com/reports/surgical-sutures-market#purchase-option
Question & Answer: Surgical Sutures Market
Question 1: What factor is expected to contribute to the growth of the surgical sutures market?
Answer: Minimally invasive surgeries are becoming increasingly popular. These procedures are milder and less stressful on the body than conventional procedures. The many benefits of minimally invasive surgery provide compared to traditional open surgery include less pain, smaller & fewer scars, lower costs, shorter hospital stays & recovery times, and overall better outcomes. These factors have raised their demand in recent years. The rise in minimally invasive surgeries is expected to contribute to the growth of the surgical sutures market.
Question 2: What factor is hampering the surgical sutures market’s growth?
Answer: Today, a number of alternative wound care treatments are available, which assist in speeding up the healing process and reducing scarring. This factor is likely to affect the adoption rate of surgical sutures, consequently hampering the market’s growth.
Question 3: Which region is presently the largest market for surgical sutures globally?
Answer: The market in North America is presently the largest globally, and is expected to continue its lead until the end of the forecast period. According to data from the Canadian Medical Protective Association (CMPA), over 1 million surgical procedures are performed in Canada every year.
Question 4: Who are the well-known players in the surgical sutures market?
Answer: Stryker Corporation, Teleflex Incorporated, Ethicon Inc (Johnson & Johnson), Boston Scientific Corporation, Smith & Nephew Plc, Advanced Medical Solutions Group Plc (AMS Group), Medtronic Plc, Demetech Corporation, Lotus Surgicals, Zimmer Biomet Holdings Inc, Conmed Corporation, Unisur Lifecare Pvt Ltd, Internacional Farmaceutica SA De CV, Corza Medical, and B Braun Melsungen AG are the well-known players in the surgical sutures market.
Related Report:
Global Surgical Site Infection Control Market
The global surgical site infection control market is deemed to register growth at a CAGR of 5.95% over the estimated phase 2021-2028. It is also expected to reap $6969.5 million in revenue by 2028.
The occurrence of complications arising from healthcare-associated infections (HAIs) is significantly rising. According to a recent study by the CDC, surgical site infections (SSIs) are the most common type of HAI and account for nearly 31% of all HAIs among patients. The estimated annual prevalence of SSIs among patients in the United States ranges from 160,000 to 300,000 individuals, with the estimated annual cost ranging from $3.5 billion to $10 billion. Thus, owing to the increased incidence of such infections, there is an alarming need to prevent them. This acts as a major driving factor for the adoption of site infection control practices, thereby aiding the growth of the market studied.
About Us:
We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.
Contact Us:
Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: [email protected]
Website: https://www.tritonmarketresearch.com/
Media ContactCompany Name: Triton Market ResearchContact Person: Matt DixsonEmail: Send EmailPhone: +44 7441 911839Address:196, wards wharf approach London E16 2EQCountry: United KingdomWebsite: https://www.tritonmarketresearch.com/
